PDB Short entry for 2OPQ HEADER TRANSFERASE 30-JAN-07 2OPQ TITLE CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN TITLE 2 COMPLEX WITH GW420867X. COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: P51 RT; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: P51; COMPND 12 EC: 2.7.7.49; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HIV-1 M:B_HXB2R; SOURCE 3 ORGANISM_TAXID: 11706; SOURCE 4 STRAIN: HXB2 ISOLATE; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DG2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PKK233-2; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HIV-1 M:B_HXB2R; SOURCE 13 ORGANISM_TAXID: 11706; SOURCE 14 STRAIN: HXB2 ISOLATE; SOURCE 15 GENE: GAG-POL; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: DG2; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PKK233-2 KEYWDS HIV-1 REVERSE TRANSCRIPTASE, AIDS, NNRTI, GW420867X, DRUG RESISTANCE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.REN,C.E.NICHOLS,P.P.CHAMBERLAIN,K.L.WEAVER,S.A.SHORT,J.H.CHAN, AUTHOR 2 J.KLEIM,D.K.STAMMERS REVDAT 5 27-DEC-23 2OPQ 1 REMARK REVDAT 4 20-OCT-21 2OPQ 1 REMARK SEQADV LINK REVDAT 3 12-NOV-14 2OPQ 1 HET HETATM HETNAM HETSYN REVDAT 3 2 1 LINK MODRES SEQRES VERSN REVDAT 2 24-FEB-09 2OPQ 1 VERSN REVDAT 1 22-MAY-07 2OPQ 0 JRNL AUTH J.REN,C.E.NICHOLS,P.P.CHAMBERLAIN,K.L.WEAVER,S.A.SHORT, JRNL AUTH 2 J.H.CHAN,J.P.KLEIM,D.K.STAMMERS JRNL TITL RELATIONSHIP OF POTENCY AND RESILIENCE TO DRUG RESISTANT JRNL TITL 2 MUTATIONS FOR GW420867X REVEALED BY CRYSTAL STRUCTURES OF JRNL TITL 3 INHIBITOR COMPLEXES FOR WILD-TYPE, LEU100ILE, LYS101GLU, AND JRNL TITL 4 TYR188CYS MUTANT HIV-1 REVERSE TRANSCRIPTASES. JRNL REF J.MED.CHEM. V. 50 2301 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17441703 JRNL DOI 10.1021/JM061117M REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1547582.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 25891 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1250 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2420 REMARK 3 BIN R VALUE (WORKING SET) : 0.4070 REMARK 3 BIN FREE R VALUE : 0.4300 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 113 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.040 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7555 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 25 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 71.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.36000 REMARK 3 B22 (A**2) : -3.34000 REMARK 3 B33 (A**2) : 2.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 30.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.47 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.970 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.310 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.510 ; 6.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.760 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 11.140; 10.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 34.45 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OPQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041434. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25926 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.71600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 69.20000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.45000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.45000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.45000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 69.20000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.45000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 43010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 64 REMARK 465 LYS A 65 REMARK 465 LYS A 66 REMARK 465 ASP A 67 REMARK 465 SER A 68 REMARK 465 THR A 69 REMARK 465 LYS A 70 REMARK 465 GLY A 444 REMARK 465 ALA A 445 REMARK 465 ALA A 446 REMARK 465 ASN A 447 REMARK 465 ARG A 448 REMARK 465 GLU A 449 REMARK 465 THR A 450 REMARK 465 LYS A 451 REMARK 465 LEU A 452 REMARK 465 GLY A 453 REMARK 465 LYS A 454 REMARK 465 TRP B 88 REMARK 465 GLU B 89 REMARK 465 VAL B 90 REMARK 465 GLN B 91 REMARK 465 LEU B 92 REMARK 465 GLY B 93 REMARK 465 ILE B 94 REMARK 465 PRO B 95 REMARK 465 LEU B 214 REMARK 465 THR B 215 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 MET B 357 REMARK 465 ARG B 358 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 HIS B 361 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 537 C - N - CA ANGL. DEV. = 9.6 DEGREES REMARK 500 PRO B 226 C - N - CA ANGL. DEV. = 14.1 DEGREES REMARK 500 TRP B 229 CA - CB - CG ANGL. DEV. = -11.4 DEGREES REMARK 500 GLY B 231 N - CA - C ANGL. DEV. = -18.6 DEGREES REMARK 500 PRO B 236 C - N - CA ANGL. DEV. = 10.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 52 4.00 -67.28 REMARK 500 GLU A 89 129.86 -30.12 REMARK 500 GLN A 91 115.35 177.23 REMARK 500 LEU A 92 -97.90 -82.45 REMARK 500 PRO A 97 -49.74 -27.85 REMARK 500 PRO A 119 165.31 -47.32 REMARK 500 PRO A 170 -72.63 -47.79 REMARK 500 MET A 184 -122.04 56.95 REMARK 500 PRO A 225 156.84 -45.04 REMARK 500 MET A 230 55.84 36.70 REMARK 500 THR A 240 -155.31 -160.35 REMARK 500 GLN A 242 166.55 -47.97 REMARK 500 SER A 268 -29.77 -39.89 REMARK 500 ILE A 270 -27.01 -156.63 REMARK 500 PRO A 345 106.18 -37.37 REMARK 500 TRP A 402 -78.51 -49.60 REMARK 500 THR A 403 3.29 -52.73 REMARK 500 PRO A 412 -165.92 -53.78 REMARK 500 LYS A 465 82.70 -151.55 REMARK 500 LYS A 528 153.73 -47.38 REMARK 500 GLN B 85 159.42 -48.90 REMARK 500 ALA B 98 3.82 -65.30 REMARK 500 PHE B 116 22.21 -65.43 REMARK 500 ASP B 121 123.73 -39.37 REMARK 500 GLU B 169 -50.19 -24.36 REMARK 500 ASN B 175 51.33 -113.73 REMARK 500 PRO B 176 -5.70 -53.48 REMARK 500 MET B 184 -123.17 43.96 REMARK 500 LEU B 193 162.43 -47.29 REMARK 500 HIS B 198 -70.84 -53.22 REMARK 500 PRO B 226 152.32 -44.31 REMARK 500 TRP B 229 -139.56 71.40 REMARK 500 MET B 230 -147.50 -88.54 REMARK 500 ASP B 250 -92.82 -66.76 REMARK 500 ILE B 270 -75.39 -79.99 REMARK 500 ARG B 277 -65.93 -13.95 REMARK 500 LEU B 283 39.50 -86.21 REMARK 500 GLN B 334 14.63 59.15 REMARK 500 PHE B 346 -29.91 74.03 REMARK 500 THR B 419 109.98 -58.15 REMARK 500 TRP B 426 -17.85 -48.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBQ A 999 DBREF 2OPQ A 4 537 UNP P04585 POL_HV1H2 591 1124 DBREF 2OPQ B 5 428 UNP P04585 POL_HV1H2 592 1015 SEQADV 2OPQ ILE A 100 UNP P04585 LEU 687 ENGINEERED MUTATION SEQADV 2OPQ CSD A 280 UNP P04585 CYS 867 MODIFIED RESIDUE SEQADV 2OPQ ILE B 100 UNP P04585 LEU 687 ENGINEERED MUTATION SEQRES 1 A 534 PRO ILE GLU THR VAL PRO VAL LYS LEU LYS PRO GLY MET SEQRES 2 A 534 ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU THR GLU GLU SEQRES 3 A 534 LYS ILE LYS ALA LEU VAL GLU ILE CYS THR GLU MET GLU SEQRES 4 A 534 LYS GLU GLY LYS ILE SER LYS ILE GLY PRO GLU ASN PRO SEQRES 5 A 534 TYR ASN THR PRO VAL PHE ALA ILE LYS LYS LYS ASP SER SEQRES 6 A 534 THR LYS TRP ARG LYS LEU VAL ASP PHE ARG GLU LEU ASN SEQRES 7 A 534 LYS ARG THR GLN ASP PHE TRP GLU VAL GLN LEU GLY ILE SEQRES 8 A 534 PRO HIS PRO ALA GLY ILE LYS LYS LYS LYS SER VAL THR SEQRES 9 A 534 VAL LEU ASP VAL GLY ASP ALA TYR PHE SER VAL PRO LEU SEQRES 10 A 534 ASP GLU ASP PHE ARG LYS TYR THR ALA PHE THR ILE PRO SEQRES 11 A 534 SER ILE ASN ASN GLU THR PRO GLY ILE ARG TYR GLN TYR SEQRES 12 A 534 ASN VAL LEU PRO GLN GLY TRP LYS GLY SER PRO ALA ILE SEQRES 13 A 534 PHE GLN SER SER MET THR LYS ILE LEU GLU PRO PHE ARG SEQRES 14 A 534 LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN TYR MET ASP SEQRES 15 A 534 ASP LEU TYR VAL GLY SER ASP LEU GLU ILE GLY GLN HIS SEQRES 16 A 534 ARG THR LYS ILE GLU GLU LEU ARG GLN HIS LEU LEU ARG SEQRES 17 A 534 TRP GLY LEU THR THR PRO ASP LYS LYS HIS GLN LYS GLU SEQRES 18 A 534 PRO PRO PHE LEU TRP MET GLY TYR GLU LEU HIS PRO ASP SEQRES 19 A 534 LYS TRP THR VAL GLN PRO ILE VAL LEU PRO GLU LYS ASP SEQRES 20 A 534 SER TRP THR VAL ASN ASP ILE GLN LYS LEU VAL GLY LYS SEQRES 21 A 534 LEU ASN TRP ALA SER GLN ILE TYR PRO GLY ILE LYS VAL SEQRES 22 A 534 ARG GLN LEU CSD LYS LEU LEU ARG GLY THR LYS ALA LEU SEQRES 23 A 534 THR GLU VAL ILE PRO LEU THR GLU GLU ALA GLU LEU GLU SEQRES 24 A 534 LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU PRO VAL HIS SEQRES 25 A 534 GLY VAL TYR TYR ASP PRO SER LYS ASP LEU ILE ALA GLU SEQRES 26 A 534 ILE GLN LYS GLN GLY GLN GLY GLN TRP THR TYR GLN ILE SEQRES 27 A 534 TYR GLN GLU PRO PHE LYS ASN LEU LYS THR GLY LYS TYR SEQRES 28 A 534 ALA ARG MET ARG GLY ALA HIS THR ASN ASP VAL LYS GLN SEQRES 29 A 534 LEU THR GLU ALA VAL GLN LYS ILE THR THR GLU SER ILE SEQRES 30 A 534 VAL ILE TRP GLY LYS THR PRO LYS PHE LYS LEU PRO ILE SEQRES 31 A 534 GLN LYS GLU THR TRP GLU THR TRP TRP THR GLU TYR TRP SEQRES 32 A 534 GLN ALA THR TRP ILE PRO GLU TRP GLU PHE VAL ASN THR SEQRES 33 A 534 PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU GLU LYS GLU SEQRES 34 A 534 PRO ILE VAL GLY ALA GLU THR PHE TYR VAL ASP GLY ALA SEQRES 35 A 534 ALA ASN ARG GLU THR LYS LEU GLY LYS ALA GLY TYR VAL SEQRES 36 A 534 THR ASN ARG GLY ARG GLN LYS VAL VAL THR LEU THR ASP SEQRES 37 A 534 THR THR ASN GLN LYS THR GLU LEU GLN ALA ILE TYR LEU SEQRES 38 A 534 ALA LEU GLN ASP SER GLY LEU GLU VAL ASN ILE VAL THR SEQRES 39 A 534 ASP SER GLN TYR ALA LEU GLY ILE ILE GLN ALA GLN PRO SEQRES 40 A 534 ASP GLN SER GLU SER GLU LEU VAL ASN GLN ILE ILE GLU SEQRES 41 A 534 GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU ALA TRP VAL SEQRES 42 A 534 PRO SEQRES 1 B 424 ILE GLU THR VAL PRO VAL LYS LEU LYS PRO GLY MET ASP SEQRES 2 B 424 GLY PRO LYS VAL LYS GLN TRP PRO LEU THR GLU GLU LYS SEQRES 3 B 424 ILE LYS ALA LEU VAL GLU ILE CYS THR GLU MET GLU LYS SEQRES 4 B 424 GLU GLY LYS ILE SER LYS ILE GLY PRO GLU ASN PRO TYR SEQRES 5 B 424 ASN THR PRO VAL PHE ALA ILE LYS LYS LYS ASP SER THR SEQRES 6 B 424 LYS TRP ARG LYS LEU VAL ASP PHE ARG GLU LEU ASN LYS SEQRES 7 B 424 ARG THR GLN ASP PHE TRP GLU VAL GLN LEU GLY ILE PRO SEQRES 8 B 424 HIS PRO ALA GLY ILE LYS LYS LYS LYS SER VAL THR VAL SEQRES 9 B 424 LEU ASP VAL GLY ASP ALA TYR PHE SER VAL PRO LEU ASP SEQRES 10 B 424 GLU ASP PHE ARG LYS TYR THR ALA PHE THR ILE PRO SER SEQRES 11 B 424 ILE ASN ASN GLU THR PRO GLY ILE ARG TYR GLN TYR ASN SEQRES 12 B 424 VAL LEU PRO GLN GLY TRP LYS GLY SER PRO ALA ILE PHE SEQRES 13 B 424 GLN SER SER MET THR LYS ILE LEU GLU PRO PHE ARG LYS SEQRES 14 B 424 GLN ASN PRO ASP ILE VAL ILE TYR GLN TYR MET ASP ASP SEQRES 15 B 424 LEU TYR VAL GLY SER ASP LEU GLU ILE GLY GLN HIS ARG SEQRES 16 B 424 THR LYS ILE GLU GLU LEU ARG GLN HIS LEU LEU ARG TRP SEQRES 17 B 424 GLY LEU THR THR PRO ASP LYS LYS HIS GLN LYS GLU PRO SEQRES 18 B 424 PRO PHE LEU TRP MET GLY TYR GLU LEU HIS PRO ASP LYS SEQRES 19 B 424 TRP THR VAL GLN PRO ILE VAL LEU PRO GLU LYS ASP SER SEQRES 20 B 424 TRP THR VAL ASN ASP ILE GLN LYS LEU VAL GLY LYS LEU SEQRES 21 B 424 ASN TRP ALA SER GLN ILE TYR PRO GLY ILE LYS VAL ARG SEQRES 22 B 424 GLN LEU CYS LYS LEU LEU ARG GLY THR LYS ALA LEU THR SEQRES 23 B 424 GLU VAL ILE PRO LEU THR GLU GLU ALA GLU LEU GLU LEU SEQRES 24 B 424 ALA GLU ASN ARG GLU ILE LEU LYS GLU PRO VAL HIS GLY SEQRES 25 B 424 VAL TYR TYR ASP PRO SER LYS ASP LEU ILE ALA GLU ILE SEQRES 26 B 424 GLN LYS GLN GLY GLN GLY GLN TRP THR TYR GLN ILE TYR SEQRES 27 B 424 GLN GLU PRO PHE LYS ASN LEU LYS THR GLY LYS TYR ALA SEQRES 28 B 424 ARG MET ARG GLY ALA HIS THR ASN ASP VAL LYS GLN LEU SEQRES 29 B 424 THR GLU ALA VAL GLN LYS ILE THR THR GLU SER ILE VAL SEQRES 30 B 424 ILE TRP GLY LYS THR PRO LYS PHE LYS LEU PRO ILE GLN SEQRES 31 B 424 LYS GLU THR TRP GLU THR TRP TRP THR GLU TYR TRP GLN SEQRES 32 B 424 ALA THR TRP ILE PRO GLU TRP GLU PHE VAL ASN THR PRO SEQRES 33 B 424 PRO LEU VAL LYS LEU TRP TYR GLN MODRES 2OPQ CSD A 280 CYS 3-SULFINOALANINE HET CSD A 280 8 HET PO4 A1301 5 HET HBQ A 999 20 HETNAM CSD 3-SULFINOALANINE HETNAM PO4 PHOSPHATE ION HETNAM HBQ ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4- HETNAM 2 HBQ DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD C3 H7 N O4 S FORMUL 3 PO4 O4 P 3- FORMUL 4 HBQ C14 H17 F N2 O3 FORMUL 5 HOH *25(H2 O) HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 ARG A 83 1 7 HELIX 3 3 HIS A 96 ILE A 100 5 5 HELIX 4 4 ALA A 114 VAL A 118 5 5 HELIX 5 5 ASP A 121 LYS A 126 1 6 HELIX 6 6 TYR A 127 ALA A 129 5 3 HELIX 7 7 GLY A 155 ASN A 175 1 21 HELIX 8 8 GLU A 194 ARG A 211 1 18 HELIX 9 9 VAL A 254 GLN A 269 1 16 HELIX 10 10 VAL A 276 LEU A 282 1 7 HELIX 11 11 THR A 296 GLU A 312 1 17 HELIX 12 12 ASN A 363 GLY A 384 1 22 HELIX 13 13 GLN A 394 THR A 403 1 10 HELIX 14 14 THR A 473 SER A 489 1 17 HELIX 15 15 SER A 499 ALA A 508 1 10 HELIX 16 16 SER A 515 LYS A 528 1 14 HELIX 17 17 THR B 27 GLU B 44 1 18 HELIX 18 18 PHE B 77 THR B 84 1 8 HELIX 19 19 GLY B 112 VAL B 118 5 7 HELIX 20 20 PHE B 124 ALA B 129 5 6 HELIX 21 21 SER B 134 GLU B 138 5 5 HELIX 22 22 LYS B 154 ASN B 175 1 22 HELIX 23 23 GLU B 194 ARG B 211 1 18 HELIX 24 24 HIS B 235 TRP B 239 5 5 HELIX 25 25 VAL B 254 GLN B 269 1 16 HELIX 26 26 VAL B 276 LEU B 283 1 8 HELIX 27 27 THR B 296 LEU B 310 1 15 HELIX 28 28 ASN B 363 GLY B 384 1 22 HELIX 29 29 GLN B 394 TRP B 402 1 9 HELIX 30 30 THR B 403 TYR B 405 5 3 HELIX 31 31 PRO B 420 TYR B 427 1 8 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N ILE A 132 O ILE A 142 SHEET 1 B 2 VAL A 60 ALA A 62 0 SHEET 2 B 2 LYS A 73 VAL A 75 -1 O LEU A 74 N PHE A 61 SHEET 1 C 3 SER A 105 ASP A 110 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 ILE A 178 TYR A 183 -1 N VAL A 179 O GLY A 190 SHEET 1 D 3 GLU A 233 LEU A 234 0 SHEET 2 D 3 LYS A 238 THR A 240 -1 O THR A 240 N GLU A 233 SHEET 3 D 3 GLY A 316 VAL A 317 -1 O GLY A 316 N TRP A 239 SHEET 1 E 2 TRP A 252 THR A 253 0 SHEET 2 E 2 VAL A 292 ILE A 293 -1 O ILE A 293 N TRP A 252 SHEET 1 F 5 LYS A 347 TYR A 354 0 SHEET 2 F 5 TRP A 337 GLU A 344 -1 N GLU A 344 O LYS A 347 SHEET 3 F 5 ILE A 326 LYS A 331 -1 N GLN A 330 O THR A 338 SHEET 4 F 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 F 5 TRP A 414 PHE A 416 1 O GLU A 415 N PHE A 389 SHEET 1 G 2 HIS A 361 THR A 362 0 SHEET 2 G 2 GLN A 512 SER A 513 -1 O GLN A 512 N THR A 362 SHEET 1 H 4 TYR A 457 THR A 459 0 SHEET 2 H 4 GLU A 438 VAL A 442 -1 N TYR A 441 O VAL A 458 SHEET 3 H 4 GLU A 492 THR A 497 1 O VAL A 496 N PHE A 440 SHEET 4 H 4 LYS A 530 TRP A 535 1 O TYR A 532 N ILE A 495 SHEET 1 I 3 ILE B 47 LYS B 49 0 SHEET 2 I 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 I 3 PHE B 130 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 J 2 VAL B 60 LYS B 65 0 SHEET 2 J 2 SER B 68 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 K 4 VAL B 179 TYR B 183 0 SHEET 2 K 4 ASP B 186 SER B 191 -1 O TYR B 188 N TYR B 181 SHEET 3 K 4 SER B 105 ASP B 110 -1 N SER B 105 O SER B 191 SHEET 4 K 4 PHE B 227 LEU B 234 -1 O LEU B 228 N VAL B 108 SHEET 1 L 2 TRP B 252 THR B 253 0 SHEET 2 L 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 M 5 LYS B 347 ALA B 355 0 SHEET 2 M 5 GLN B 336 GLU B 344 -1 N ILE B 341 O LEU B 349 SHEET 3 M 5 ILE B 326 GLY B 333 -1 N GLN B 330 O THR B 338 SHEET 4 M 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 M 5 GLU B 413 PHE B 416 1 O GLU B 415 N LEU B 391 LINK C LEU A 279 N CSD A 280 1555 1555 1.32 LINK C CSD A 280 N LYS A 281 1555 1555 1.33 CISPEP 1 PRO A 225 PRO A 226 0 0.19 CISPEP 2 PRO A 420 PRO A 421 0 -0.11 SITE 1 AC1 6 GLY A 436 ALA A 437 ASN A 460 ARG A 461 SITE 2 AC1 6 LYS B 82 ALA B 288 SITE 1 AC2 11 ILE A 100 LYS A 101 VAL A 179 TYR A 181 SITE 2 AC2 11 TYR A 188 GLY A 190 PHE A 227 LEU A 234 SITE 3 AC2 11 HIS A 235 TYR A 318 HOH B1025 CRYST1 138.400 114.900 64.900 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007225 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008703 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015408 0.00000